logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Pharmaceutical
Filter

Pharmaceutical

Categories

Sectors

Locations

Exchange

中国成都先导与Kymera达成基于DNA编码化合物库的新药研发合作

HitGen Enters into DNA-Encoded Library Based Drug Discovery Research Collaboration with Kymera

Jan 14, 2020

Life Science

医疗保健精选—— Lexaria Bio与Cannadips合作,Heska收购Covetrus

Healthcare Roundup – Lexaria Bio teams up with Cannadips, Heska to acquire Covetrus

Jan 14, 2020

Life Science

CP Logistics, LLC Files Motion To Compel Arbitration In Dispute With Sunniva Production Campus, LLC and Announces The Resignation Of A Board Member

Jan 14, 2020

Life Science

中国生物制药携手美国企业,开发下一代生物制剂

Ambrx and Sino Biopharma Announce Collaboration to Develop Two Next-Generation Biologics

Jan 13, 2020

Life Science

Healthcare Roundup – NeoGenomics acquires Human Longevity’s oncology division, HCA acquires Valify

Jan 10, 2020

Life Science

Healthcare Roundup – Heska announces acquisition of CVM Companies, Lilly launches new robotic drug discovery laboratory

Jan 9, 2020

Life Science

醫療保健精選——FDA批准默克公司的Keytruda治療抗藥性膀胱癌,Catabasis Pharma與英國DMD慈善機構合作開展edasalonexent研究

Healthcare Roundup – FDA OKs Merck’s Keytruda, Catabasis Pharma teams up with UK DMD charity

Jan 8, 2020

Life Science

中国奥赛康引进英国Shield Therapeutics产品

Chinese Drugmaker Aosaikang to Bring in Oral Iron Supplement From UK’s Shield Therapeutics

Jan 8, 2020

Life Science

Healthcare Roundup – Genetic Tech up 95%, General Cannabis to acquire Hälsa Holdings

Jan 7, 2020

Life Science

Gracell Initiates Investigational Study of the Technological Breakthrough TruUCAR™ Therapy for Relapsed or Refractory T-cell Malignancies

Jan 7, 2020

Life Science

GlycoMimetics向中国授出两项候选药物的许可授权,OrthoPediatrics出售Vilex成人业务

Healthcare Roundup – GlycoMimetics out-licenses two programs, OrthoPediatrics sells Vilex adult business

Jan 6, 2020

Life Science

NuProbe与阅尔基因合并

Biotech Co. Ltd. Announced Completion of Merger, Appointed Yingshuang Chai as CEO, and Established Collaboration with Illumina

Jan 6, 2020

Life Science

依生生物和美国Tavotek生物制药公司

Yisheng Biopharma and Tavotek Biotherapeutics Announce Strategic Research Alliance for Development of YS-ON-001/002 and Tavo-301/303 Combination Therapy for Cancer Treatment

Jan 6, 2020

Life Science

Leap Therapeutics和百济神州宣布就DKN-01达成独家选择权和授权许可协议

Leap Therapeutics and BeiGene Announce Exclusive Option and License Agreement for DKN-01 and Leap Announces $27 Million Equity Financing

Jan 3, 2020

Life Science

医疗保健综述——MyoKardia与Cowen达成股票销售协议,Charles River Labs收购HemaCare

Healthcare Roundup – MyoKardia inks $200M stock sales deal, Charles River Labs closes HemaCare acquisition

Jan 3, 2020

Life Science

Illumina和Pacific Biosciences终止合并,Tilray出口大麻

Healthcare Roundup – Illumina and Pacific Biosciences nix merger, Tilray inks deal to export weed into Israel

Jan 2, 2020

Life Science

Sunniva Responds To Filing Of Notice Of Claim With Respect To Finder’s Fee Agreement

Jan 2, 2020

Life Science

中国批准国产13价肺炎疫苗上市

China approves home-grown vaccines, offering alternative to global drugmakers’ products

Dec 31, 2019

Life Science

  • ‹‹ Previous
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada